REFERENCES
- Link MP, Weinstein HJ. Malignant non-Hodgkin lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice Of Pediatric Oncology, 5th ed. Philadelphia: Lippincott Williams&Wilkins, 2006:722–749.
- Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodking's lymphoma incidence and survival in European children and adolescents(1978–1997): report from the Automated Childhood Cancer Information. Eur J Cancer. 2006;42:2050–2063.
- Sanlund JT, Downing JR, Crist WM. Non-Hodking's lymphoma in childhood. N Engl J Med. 1996;334(19):1238–1248.
- Reiter A, Schrabbe M, Parwaresch R, Non-Hodking's lymohomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage-a report of the Berlin-Frankfurt-Munster group. J Clin Oncol. 1995;13:359–372.
- Windsor R, Stiller C, Webb D. Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years. Pediatr Blood Cancer. 2008;50(4):784–787.
- Arrowsmith ER, Macon WR, Kinney MC, Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the Revised European-American Lymphoma Classi- fication. Leuk Lymphoma 2003;44:241–249.
- Reich A, Wróbel G, Kazanowska B, Skin involvement in highly malignant non-Hodgkin lymphomas of childhood and adolescence. Acta Dermatovenerol Alp Panonica Adriat. 2006;15(4):158–168.
- Daar G, Küpeli S, Yalçın B, Primary cutaneous anaplastic large cell lymphoma. Pediatr Hematol Oncol. 2010;27(7):558–563.
- Reiter A, Schrappe M, Ludwig WD, Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children withT-cell lymphoblastic lymphoma: a BFM Group report. Blood. 2000;95:416–421.